Genomics and omics

DNA repair and genomic instability

6 papers and 6 abstracts co-authored by Raphael E. Szalat. Current lab members are shown in bold.

Papers 6

  1. 2020

    Genomic Instability in Multiple Myeloma

    Alagpulinsa DA, Szalat RE, Poznansky MC, Shmookler Reis RJ

    Trends in Cancer6(10):858-873DOI: Genomic Instability in Multiple MyelomaPubMed: Genomic Instability in Multiple Myeloma

  2. 2019

    Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma

    Alagpulinsa DA, Kumar S, Talluri S, …, Szalat R, …, Munshi NC

    Blood Advances3(23):3968-3972DOI: Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myelomaPubMed: Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma

  3. 2019

    Functional profiling of nucleotide Excision repair in breast cancer

    Rajkumar-Calkins AS, Szalat R, Dreze M, …, Mouw KW

    DNA Repair82:102697DOI: Functional profiling of nucleotide Excision repair in breast cancerPubMed: Functional profiling of nucleotide Excision repair in breast cancer

  4. 2019

    Rôle des voies de réparation des dommages de l'ADN dans l'instabilité génomique observée au cours du myélome multipleThesis

    Szalat R

    Doctoral thesis, Université Sorbonne Paris CitéDOI: Rôle des voies de réparation des dommages de l'ADN dans l'instabilité génomique observée au cours du myélome multiple

  5. 2018

    Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

    Walker BA, Mavrommatis K, Wardell CP, …, Szalat R, …, Morgan GJ

    Blood132(6):587-597DOI: Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaPubMed: Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

  6. 2017

    Nucleotide excision repair is a potential therapeutic target in multiple myeloma

    Szalat R, Samur MK, Fulciniti M, …, Munshi NC

    Leukemia32(1):111-119DOI: Nucleotide excision repair is a potential therapeutic target in multiple myelomaPubMed: Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Abstracts & posters 6

  1. 2019

    E2 ubiquitin conjugase UBE2T contributes to genome maintenance through homologous recombination in multiple myeloma

    Alagpulinsa D, Kumar S, Talluri S, …, Szalat R, …, Munshi N

    Clinical Lymphoma Myeloma and Leukemia19(10):e139DOI: E2 ubiquitin conjugase UBE2T contributes to genome maintenance through homologous recombination in multiple myeloma

  2. 2018

    DNA repair processes target transcribed region in multiple myeloma

    Samur M, Szalat R, Lawlor M, Maura F, Ott C, Bolli N, Anderson K, et al.

    HEMASPHERE2(S1):211-211

  3. 2017

    Bone marrow microenvironment induces genomic instability and enables clonal evolution in multiple myeloma

    Perini T, Szalat R, Fulciniti M, Samur MK, Lopez MA, Nanjappa P, Wen K, et al.

    Blood130:4408

  4. 2015

    Dysregulated Nucleotide Excision Repair (NER) Is a New Target in Multiple Myeloma

    Szalat R, Samur MK, Cleynen A, …, Munshi NC

    Blood126(23):4187-4187DOI: Dysregulated Nucleotide Excision Repair (NER) Is a New Target in Multiple Myeloma

  5. 2015

    Measurement of nucleotide excision repair activity and correlation with cisplatin sensitivity.

    Calkins A, Szalat R, Dreze M, Schnorenberg M, Ceccaldi R, Iglehart JD, Lazaro JB

    Journal of Clinical Oncology33(15_suppl):1077-1077DOI: Measurement of nucleotide excision repair activity and correlation with cisplatin sensitivity.

  6. 2014

    Nucleotide Excision Repair (NER) Is Frequently Impaired and Affects Outcome in Multiple Myeloma (MM)

    Szalat R, Dreze M, Samur MK, …, Munshi NC

    Blood124(21):2055-2055DOI: Nucleotide Excision Repair (NER) Is Frequently Impaired and Affects Outcome in Multiple Myeloma (MM)